# Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

> **NCT01483027** · NA · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 428 (actual)

## Conditions studied

- Colorectal Cancer Metastatic

## Interventions

- **DEVICE:** TheraSphere

## Key facts

- **NCT ID:** NCT01483027
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2020-08-31
- **Final completion:** 2020-08-31
- **Target enrollment:** 428 (ACTUAL)
- **Last updated:** 2022-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01483027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01483027, "Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01483027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*